[Summary] Gene technology benefits humanity
BGI Genomics Co., Ltd. (hereinafter referred to as "BGI Genomics" or "the Company") was officially listed on July 14, 2017, becoming the 2,001st listed company on the Shenzhen Stock Exchange.
As a pioneer in China's genomics industry, BGI Genomics upholds the mission of "gene technology for the benefit of humanity". Through over 20 years of talent accumulation, scientific research, and industrial development, it has established a marketing and service network covering more than 100 countries worldwide and all provinces, municipalities, and autonomous regions in China. It has become one of the few technology companies covering the entire industrial chain and all application fields in the industry. Based on its advanced technology, complete configuration, and leading-scale multi-omics production platforms, it has become one of the world's few scientific technology service providers and precision medical service operators.
The Company's main business is to provide research services and comprehensive precision medicine testing solutions to scientific research institutions, enterprises, medical institutions, and public health organizations through multi-omics big data technologies such as gene testing, mass spectrometry testing, and bioinformatics analysis. With the goal of advancing life science research, the application of life big data, and improving global healthcare levels, BGI Genomics is committed to accelerating technological innovation, safeguarding the community of shared health for mankind, and reducing the harm of major diseases to humans. This is achieved by reducing birth defects, strengthening tumor prevention and control, precisely curing infections, promoting chronic disease prevention, and facilitating precision medicine.
The Company is headquartered in Shenzhen, China, with branch offices and medical laboratories in major domestic cities including Beijing, Tianjin, Wuhan, Shanghai, and Guangzhou. It also has overseas centers and core laboratories in Hong Kong, Europe, Asia-Pacific, the Middle East, and other regions. The Company has formed a network layout that "covers the whole country and radiates globally", with business reaching over 100 countries and regions. This includes more than 2,000 scientific research institutions and over 2,400 medical institutions in China, of which more than 600 are tertiary hospitals. In Europe, the Americas, and Asia-Pacific, it cooperates with over 3,000 overseas medical and scientific research institutions, and has established cooperative relationships with health regulatory authorities in more than 30 countries and regions.
What does BGI Genomics Co., Ltd. require? Who is BGI Genomics hiring? BGI Genomics recruitment: 销售类占比最多占29.9%,其次是计算机/网络/技术类占23.2%. What education can get in at BGI Genomics? 本科占比最多占43.4%,其次是不限占29%. High education required at BGI Genomics? 硕士占21.2%,博士占3.4%. Work experience required at BGI Genomics? 不限占比最多占44.6%,其次是1-3年占20.3%. Where are the job locations at BGI Genomics? 深圳占比最多占48.9%,其次是武汉占10.9%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows